152 related articles for article (PubMed ID: 28807470)
21. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?
Eikelboom JW; Karthikeyan G; Fagel N; Hirsh J
Chest; 2009 Feb; 135(2):513-520. PubMed ID: 19201714
[TBL] [Abstract][Full Text] [Related]
22. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases.
Wei Z; Liu M
Transfus Med; 2015 Jun; 25(3):151-62. PubMed ID: 26033447
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
Khaldi A; Helo N; Schneck MJ; Origitano TC
J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
Kaatz S; Spyropoulos AC
Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
[TBL] [Abstract][Full Text] [Related]
26. Proximal deep venous thrombosis and pulmonary embolus following total joint arthroplasty.
Parvizi J; Parmar R; Raphael IJ; Restrepo C; Rothman RH
J Arthroplasty; 2014 Sep; 29(9):1846-8. PubMed ID: 24845718
[TBL] [Abstract][Full Text] [Related]
27. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
28. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
Eikelboom JW; Quinlan DJ; Douketis JD
Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
[TBL] [Abstract][Full Text] [Related]
29. The incidence and prevention of symptomatic thromboembolic disease following unicompartmental knee arthroplasty.
Lombardi AV; Berend KR; Tucker TL
Orthopedics; 2007 May; 30(5 Suppl):46-8. PubMed ID: 17549868
[TBL] [Abstract][Full Text] [Related]
30. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
31. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW;
J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879
[TBL] [Abstract][Full Text] [Related]
32. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Amin AN; Lin J; Thompson S; Wiederkehr D
Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
[TBL] [Abstract][Full Text] [Related]
33. Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials.
Mearns ES; Coleman CI; Patel D; Saulsberry WJ; Corman A; Li D; Hernandez AV; Kohn CG
J Thromb Haemost; 2015 Jun; 13(6):1043-52. PubMed ID: 25819920
[TBL] [Abstract][Full Text] [Related]
34. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
35. Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty.
Hamilton WG; Reeves JD; Fricka KB; Goyal N; Engh GA; Parks NL
J Arthroplasty; 2015 Jan; 30(1):43-5. PubMed ID: 25224874
[TBL] [Abstract][Full Text] [Related]
36. A mobile compression device for thrombosis prevention in hip and knee arthroplasty.
Colwell CW; Froimson MI; Anseth SD; Giori NJ; Hamilton WG; Barrack RL; Buehler KC; Mont MA; Padgett DE; Pulido PA; Barnes CL
J Bone Joint Surg Am; 2014 Feb; 96(3):177-83. PubMed ID: 24500578
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis.
Levy YD; Hardwick ME; Copp SN; Rosen AS; Colwell CW
J Arthroplasty; 2013 Mar; 28(3):474-8. PubMed ID: 23142435
[TBL] [Abstract][Full Text] [Related]
38. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial.
Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM
Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467
[TBL] [Abstract][Full Text] [Related]
39. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
Friedman RJ
Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
